HCW Biologics (HCWB) Research & Development (2020 - 2026)
HCW Biologics' Research & Development was $1.2 million in Q2 2026, down 1.9% from $1.23 million a year earlier.
Powered by 
Analysis
HCW Biologics (HCWB) Research & Development (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, HCW Biologics' Research & Development was $5.17 million through Jun 30, 2026, up 4.6% year-over-year; for FY2025, it came in at $5.44 million, down 14.8% from FY2024.
- Research & Development has now declined for three consecutive years, with a five-year compound annual growth rate of -5.6% (FY2020 to FY2025).
- In earlier years, Research & Development was $6.39 million in FY2024 (-16.8%), $7.68 million in FY2023 (-17.8%), $9.34 million in FY2022 (+14.2%) and $8.17 million in FY2021 (+12.7%).
- The Q2 2026 figure marks the lowest quarterly Research & Development since Q4 2024.
- Compared with a year earlier, Research & Development was higher in two of the last seven quarters, with an average decline of 15.2%.
- The best year-over-year quarter for Research & Development over five years was Q4 2022 (growth of 97.5%); the worst was Q4 2024 (a decline of 50.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 993.80 Mn |
| 10 | HCW Biologics | 2.27 Mn | -3.96 Mn | -93,887.00 | 1.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.20 Mn |
| Dec 31, 2025 | 1.33 Mn |
| Sep 30, 2025 | 1.40 Mn |
| Jun 30, 2025 | 1.23 Mn |
| Mar 31, 2025 | 1.48 Mn |
| Dec 31, 2024 | 1.05 Mn |
| Sep 30, 2024 | 1.19 Mn |
| Jun 30, 2024 | 2.03 Mn |
| Mar 31, 2024 | 2.12 Mn |
| Dec 31, 2023 | 2.14 Mn |
| Sep 30, 2023 | 1.67 Mn |
| Jun 30, 2023 | 1.62 Mn |
| Mar 31, 2023 | 2.26 Mn |
| Dec 31, 2022 | 2.93 Mn |
| Sep 30, 2022 | 2.65 Mn |
| Jun 30, 2022 | 1.97 Mn |
| Mar 31, 2022 | 1.79 Mn |
| Dec 31, 2021 | 1.48 Mn |
| Sep 30, 2021 | 2.69 Mn |
| Jun 30, 2021 | 1.67 Mn |
API Access
HCW Biologics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=HCWB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "HCWB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=HCWB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();